Non-small Cell Lung Cancer: Seven-Market Drug Forecast and Market Analysis
Summary
This report covers the 7MM (US, France, Germany, Italy, Spain, UK, and Japan) and includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 7MM for marketed and late-stage pipeline therapies, with a launch date assessment by market for non-small cell lung cancer (NSCLC).
These sales forecasts leverage data on pharmaceutical sales and drug availability from GlobalData’s World Markets Healthcare (WMH) and POLI Price Intelligence databases.
Key Highlights
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook